EN CN


In Vitro Safety Assessment

Return

Kinase Panel Screening for Drug Discovery

Kinases are vital regulators of cellular signalling and important therapeutic research targets. Our kinase panels support early drug discovery by helping identify and evaluate the potential of kinase inhibitors, with a range of panel formats designed for diverse research needs.

Panel Portfolio

Kinome panels for focused to comprehensive profiling

ICEKP™ Kinome Panel CDK
24 kinases

Focused CDK panel for cell-cycle and transcriptional regulation research.

ICEKP™ Kinome Panel TK
76 kinases

Tyrosine kinase-focused panel for signal-transduction and oncology research.

ICEKP™ Kinome Panel 80
80 kinases

Economical, rapid and efficient screening focused on core wild-type kinases.

ICEKP™ Kinome Panel 330
330 kinases

A broad spectrum of wild-type kinases for comprehensive profiling studies.

ICEKP™ Kinome Panel 416
416 kinases

The most comprehensive panel, covering human-origin wild-type and mutant kinases.

Our Features

Designed for confident kinase profiling

01 Comprehensive Coverage

A broad spectrum of kinase targets supports thorough analysis and evaluation.

02 High-Performance Assay Technology

HTRF and ADP-Glo platforms deliver precise, reproducible and rapid kinase activity measurements with flexible configurations for diverse research needs.

03 Near-Physiological Testing Options

For selected kinases, assays can be performed under 1 mM ATP conditions to provide enhanced physiological relevance and more predictive insight into compound efficacy.

04 Expertise and Precision

Our experienced team delivers accuracy, consistency and insightful interpretation in functional kinase profiling.

Reference Data

Visualize kinase selectivity with confidence

Reference data can help illustrate compound activity across kinase families, supporting the early identification of selectivity profiles and potential off-target effects.

Kinase Panel Screening Reference Data

Kinase inhibition dendrogram

Kinase inhibition dendrogram

This kinase inhibition dendrogram illustrates the inhibitory efficacy of BI-3406 at 1 µM across a spectrum of kinase families. Kinases are grouped by phylogenetic relationship, including TK, CMGC, AGC, CAMK, CK1, STE and TKL.

Each kinase is marked with a dot, with colour indicating inhibition: red, 90–100%; yellow, 80–90%; blue, 70–80%; light blue, 50–70%; and green, below 50%. This visualization helps identify selectivity profiles, potential therapeutic targets and possible off-target effects relevant to drug development and safety assessment.


Contact Us

We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.

We are a CRO service organization, not a hospital




Get a quote

Go top